Functional assessment in schizophrenia has become a recent NIMH priority (PA-05-037). The cognitive deficits associated with the illness are potentially important factors limiting functional recovery from the disorder. Research has suggested that deficits in social cognition may be particularly important to functional outcome. Unfortunately, reliable and valid social-cognitive assessments are sparse. The broad goal of this research is to contribute to the ongoing efforts of elucidating the functional significance of social-cognitive deficits in schizophrenia and the relevance of such deficits as specific targets for future schizophrenia treatments, through the examination of a promising measure of social cognition. Specifically, this project proposes to conduct a preliminary investigation on the use of the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT), a promising ability-based measure of emotional intelligence (and also included in the NIMH-MATRICS battery), for assessing social cognition in schizophrenia. This will be accomplished by utilizing longitudinal data from an ongoing trial of Cognitive Enhancement Therapy to estimate the reliability, validity, and longitudinal contribution to functional outcome of the MSCEIT as applied to individuals with schizophrenia. Results will be used to propose a systematic plan of research to conduct a more comprehensive validation of the MSCEIT and initiate the development of treatments to remediate social-cognitive deficits evinced by this instrument that have direct bearing on functional outcome. The results of this research have the potential to make an important public health contribution by pointing to the importance of social-cognitive deficits to social and functional disability in schizophrenia, and providing a preliminary systematic evaluation of a promising instrument to measure these deficits. These results will be used to contribute to ongoing scientific efforts to understand the cognitive correlates of functional disability in schizophrenia and develop targeted treatment strategies to improve social and behavioral outcomes among this population. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31MH079537-01A1
Application #
7274401
Study Section
Special Emphasis Panel (ZRG1-F12B-J (20))
Program Officer
Mayo, Donna J
Project Start
2007-08-01
Project End
2009-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
1
Fiscal Year
2007
Total Cost
$31,518
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Wojtalik, Jessica A; Eack, Shaun M; Keshavan, Matcheri S (2013) Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 40:207-12
Wojtalik, Jessica A; Eack, Shaun M; Pollock, Bruce G et al. (2012) Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia. Psychiatry Res 204:61-7
Eack, Shaun M; Hogarty, Gerard E; Greenwald, Deborah P et al. (2011) Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial. Res Soc Work Pract 21:32-42
Lewandowski, Kathryn E; Eack, Shaun M; Hogarty, Susan S et al. (2011) Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder? Schizophr Res 125:291-4
Eack, S M; Pogue-Geile, M F; Greenwald, D P et al. (2011) Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia. Psychol Med 41:1253-61
Eack, Shaun M; Greenwald, Deborah P; Hogarty, Susan S et al. (2010) One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophr Res 120:210-6
Eack, Shaun M; Greeno, Catherine G; Pogue-Geile, Michael F et al. (2010) Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophr Bull 36:370-80
Eack, Shaun M; Hogarty, Gerard E; Cho, Raymond Y et al. (2010) Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 67:674-82
Eack, Shaun M; Mermon, Diana E; Montrose, Debra M et al. (2010) Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull 36:1081-8
Eack, Shaun M; Greenwald, Deborah P; Hogarty, Susan S et al. (2009) Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv 60:1468-76

Showing the most recent 10 out of 15 publications